Fundraising Fox
Xylo
Sydney, AU · 33 employees on LinkedIn · 9 known investors
Find your way into Xylo
Sign up to find every way you can get introduced to Xylo
- Your email: who you already know at Xylo, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Xylo team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches. The company serves patients and healthcare systems seeking novel treatments for complex neuropsychiatric conditions.
Founders & leadership
Investors · 9
How we know: Palo Santo VC's portfolio page · Not right? Tell us
How we know: funding news · thesaasnews.com · Not right? Tell us
How we know: thesaasnews.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountseedJul 2026
CapitalT (lead)
Source ↗ - Undisclosed amountpre-seedJul 2026 · 2 sources
CapitalT (lead), Common Magic, Endurance Ventures, Sure Valley Ventures, Tiny VC
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Xylo do?
- Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches. The company serves patients and healthcare systems seeking novel treatments for complex neuropsychiatric conditions.
- Who founded Xylo?
- Xylo was founded by Joshua Ismin, Dr. Sam Banister.
- Who are Xylo's investors?
- Xylo's investors include Palo Santo VC, Radar Ventures, Tenmile, XEIA Venture Partners, CapitalT, Common Magic, Sure Valley Ventures.
- Where is Xylo headquartered?
- Xylo is headquartered in Sydney, AU.